Receptor-Targeted Gene Delivery Using Multivalent Phagemid Particles

نویسندگان
چکیده

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Cell-targeted phagemid particles preparation using Escherichia coli bearing ligand-pIII encoding helper phage genome.

Benchmarks The filamentous phages M13, f1, and fd have been widely applied in biological research such as phage display library, phage gene delivery, and antigen preparation (1). For phagemid-mediated gene delivery, we have previously reported that modified helper phage M13KO7P1, which encodes a 12-mer ligand peptide and pIII fusion, could be used to rescue phagemid that encodes the gene of int...

متن کامل

Preparation of peptide-targeted phagemid particles using a protein III-modified helper phage.

Ligand or peptide-targeted phagemid particles are being pursued as vehicles for receptor-mediated gene delivery. Here we describe a helper phage in which the protein III (pIII) protein is modified by the addition of a ligand peptide sequence at the amino terminus. Phagemid particles can be prepared with the help of this modified helper phage and should display the ligand peptide in most of the ...

متن کامل

Transferrin Receptor Targeted Delivery Of Sirna For Gene Therapy

TRANSFERRIN RECEPTOR TARGETED DELIVERY OF SIRNAFOR GENE THERAPY

متن کامل

Targeted synthetic gene delivery vectors.

Synthetic gene delivery vehicles have made significant progress in the past decade in demonstrating strong potential for targeted delivery to specific cells, low toxicity and immunogenicity and large carrying capacity. However, significant advances must still be made to increase the efficiency of both polymer and lipid vehicles. Furthermore, techniques to generate more effective targeting moiet...

متن کامل

Tropism-Modification Strategies for Targeted Gene Delivery Using Adenoviral Vectors

Achieving high efficiency, targeted gene delivery with adenoviral vectors is a long-standing goal in the field of clinical gene therapy. To achieve this, platform vectors must combine efficient retargeting strategies with detargeting modifications to ablate native receptor binding (i.e. CAR/integrins/heparan sulfate proteoglycans) and "bridging" interactions. "Bridging" interactions refer to co...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Molecular Therapy

سال: 2001

ISSN: 1525-0016

DOI: 10.1006/mthe.2001.0284